000143227 001__ 143227
000143227 005__ 20240229112545.0
000143227 0247_ $$2doi$$a10.1186/s12883-019-1267-9
000143227 0247_ $$2pmid$$apmid:30849952
000143227 0247_ $$2pmc$$apmc:PMC6407211
000143227 0247_ $$2altmetric$$aaltmetric:57038996
000143227 037__ $$aDKFZ-2019-00826
000143227 041__ $$aeng
000143227 082__ $$a610
000143227 1001_ $$aJoisten, Niklas$$b0
000143227 245__ $$aInfluence of different rehabilitative aerobic exercise programs on (anti-) inflammatory immune signalling, cognitive and functional capacity in persons with MS - study protocol of a randomized controlled trial.
000143227 260__ $$aHeidelberg$$bSpringer$$c2019
000143227 3367_ $$2DRIVER$$aarticle
000143227 3367_ $$2DataCite$$aOutput Types/Journal article
000143227 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1634735142_21234
000143227 3367_ $$2BibTeX$$aARTICLE
000143227 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000143227 3367_ $$00$$2EndNote$$aJournal Article
000143227 520__ $$aStudies have shown positive effects of therapeutic exercise on motor- and cognitive function as well as on psychosocial outcomes in persons with multiple sclerosis (MS). A reduction of inflammatory stress through physical exercise has been suspected as one key mechanism, mediating the positive effects of exercise in the context of MS. The primary objective of this trial is to investigate the acute and chronic effects of different exercise modalities on (anti-)inflammatory immune signalling as well as on cognitive and functional capacity in persons with MS.A two armed single-blind randomized controlled design will investigate 72 persons with relapsing remitting or secondary progressive MS (EDSS 3.0-6.0), during 3 weeks of inpatient rehabilitation. Participants will be randomized into either a high-intensity interval training (HIIT) or a moderate continuous training group; the latter represents the local standard therapy (ST). Both groups will exercise 3x per week. The HIIT group will perform 5 × 1.5-min high-intensive exercise bouts at 95-100% of their maximum heart rate (HRmax) followed by active breaks of unloaded pedalling (60% HRmax) for 2 min. In contrast, the ST group will exercise for 24 min continuously at 65% of HRmax. The proportion of circulating regulatory T-cells will be measured as primary outcome. Secondary outcomes comprise numbers and proportions of further immune cells including Th17-cells, soluble factors ((anti-) inflammatory cytokines, tryptophan metabolites), endurance capacity, cognitive performance, processing skills for activities of daily living, fatigue, depression and healthcare-related quality of life. Outcomes will be assessed before (T0) and after (T3) the 3-week exercise intervention program. Blood samples of T0 will be taken immediately before the first exercise session. Additionally, blood samples for the soluble factors will be collected immediately after (T1) and three hours (T2) after the first exercise session of each group.This study will be the first to investigate both acute and chronic effects of aerobic exercise on immune function and disease associated biomarkers in persons with MS. Combining biological analyses with cognitive and functional capacity assessments may contribute to a better understanding of responses to rehabilitative training, needed to improve exercise recommendations for persons with MS.This trial was prospectively registered at ClinicalTrials.gov ( NCT03652519 ; 29 August 2018).
000143227 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000143227 588__ $$aDataset connected to CrossRef, PubMed,
000143227 7001_ $$aRademacher, Annette$$b1
000143227 7001_ $$aBloch, Wilhelm$$b2
000143227 7001_ $$aSchenk, Alexander$$b3
000143227 7001_ $$aOberste, Max$$b4
000143227 7001_ $$aDalgas, Ulrik$$b5
000143227 7001_ $$aLangdon, Dawn$$b6
000143227 7001_ $$aCaminada, Daniel$$b7
000143227 7001_ $$aPurde, Mette-Triin$$b8
000143227 7001_ $$aGonzenbach, Roman$$b9
000143227 7001_ $$aKool, Jan$$b10
000143227 7001_ $$0P:(DE-He78)d05b24af674d8ef2c455634434b67770$$aZimmer, Philipp$$b11$$eLast author
000143227 7001_ $$aBansi, Jens$$b12
000143227 773__ $$0PERI:(DE-600)2041347-6$$a10.1186/s12883-019-1267-9$$gVol. 19, no. 1, p. 37$$n1$$p37$$tBMC neurology$$v19$$x1471-2377$$y2019
000143227 909CO $$ooai:inrepo02.dkfz.de:143227$$pVDB
000143227 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d05b24af674d8ef2c455634434b67770$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000143227 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000143227 9141_ $$y2019
000143227 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBMC NEUROL : 2017
000143227 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000143227 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000143227 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000143227 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000143227 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000143227 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000143227 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Open peer review
000143227 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000143227 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000143227 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000143227 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000143227 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000143227 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000143227 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000143227 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000143227 9201_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Präventionsforschung und Krebs$$x0
000143227 980__ $$ajournal
000143227 980__ $$aVDB
000143227 980__ $$aI:(DE-He78)C110-20160331
000143227 980__ $$aUNRESTRICTED